AWD131-138 is primarily utilized in the field of pharmaceutical research and development, where it serves as a key compound in the study of metabolic disorders. Its application is significant in the investigation of potential treatments for conditions such as diabetes and obesity, as it has shown promise in modulating metabolic pathways. Researchers are particularly interested in its ability to influence glucose metabolism and lipid regulation, which could lead to the development of novel therapeutic agents. Additionally, AWD131-138 is being explored for its potential role in enhancing insulin sensitivity, making it a valuable candidate for further clinical studies aimed at improving the management of metabolic syndromes.